Baroggi N et al. |
Changes in cytosolic free calcium induced by platelet-activating factor in rabbit platelets: specific inhibition by BN 52021 and structurally related compounds. |
1986 |
Agents Actions Suppl. |
pmid:3028108
|
Bertrand C et al. |
Selective implication of thromboxane A2 and PAF-acether in two guinea pig anaphylactic models. |
1990 |
Agents Actions Suppl. |
pmid:2080755
|
Tsunoda H et al. |
Effects of a novel PAF antagonist, E6123, on PAF-induced biological responses. |
1990 |
Agents Actions Suppl. |
pmid:2080757
|
Sakuma Y et al. |
Effects of a novel PAF antagonist, E6123, on passive anaphylaxis. |
1990 |
Agents Actions Suppl. |
pmid:2080758
|
Rihoux JP |
The inhibiting effect of cetirizine 2 HC1 on eosinophil migration and its link to H1 blockade. |
1991 |
Agents Actions Suppl. |
pmid:1675836
|
König W et al. |
On the biological role of lipid chemotactic factors. |
1983 |
Agents Actions Suppl. |
pmid:6404145
|
Kurosawa M |
Effect of platelet activating factor on histamine release from rat mast cells. |
1987 |
Agents Actions Suppl. |
pmid:2445185
|
Goldie RG et al. |
PAF receptors in guinea-pig and human lung. |
1990 |
Agents Actions Suppl. |
pmid:1964365
|
Parnham MJ et al. |
Regulation of the oxidative burst of macrophages by lipid mediators. |
1984 |
Agents Actions Suppl. |
pmid:6433680
|
Schrör K and Felsch A |
Ramiprilat prevents PAF-induced myocellular and endothelial injury in a neutrophil-perfused heart preparation. |
1992 |
Agents Actions Suppl. |
pmid:1334351
|
Alabaster VA et al. |
UK-74,505, a novel and selective PAF antagonist, exhibits potent and long lasting activity in vivo. |
1991 |
Agents Actions Suppl. |
pmid:1793066
|
Heuer HO |
The effects of hetrazepine PAF antagonists in preclinical models of asthma. |
1991 |
Agents Actions Suppl. |
pmid:1793067
|
Mazzoni L et al. |
Changes in airway sensitivity to histamine are not necessarily paralleled by changed sensitivity to acetylcholine. |
1991 |
Agents Actions Suppl. |
pmid:1793069
|
Soloviev A and Braquet P |
The similarity in action of hypoxia and platelet-activating factor on smooth muscle cells of coronary arteries: possible explanation for hypoxic coronary spasm development. |
1995 |
Agents Actions Suppl. |
pmid:7717190
|
Billah MM et al. |
Sch 37370: a new drug combining antagonism of platelet-activating factor (PAF) with antagonism of histamine. |
1991 |
Agents Actions Suppl. |
pmid:1793070
|
Saeed SA et al. |
Inhibitory effect of oral ketotifen on ex vivo platelet activating factor-induced platelet aggregation. |
1991 |
Agents Actions Suppl. |
pmid:1793071
|
Anderson GP and Fennessy MR |
Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. |
1988 |
Agents Actions Suppl. |
pmid:3140616
|
Page CP et al. |
Drugs affecting pulmonary responses to platelet activating factor as novel anti-asthma drugs. |
1988 |
Agents Actions Suppl. |
pmid:3051932
|
Hoshiko K et al. |
Histamine(H1) antagonists and airway hyperreactivity in the guinea-pig. |
1991 |
Agents Actions Suppl. |
pmid:1686527
|
Muirhead EE |
Vasodepressor lipid of the renomedullary interstitial cells of the renal papilla is a prohormone activated by the liver. |
1987 |
Agents Actions Suppl. |
pmid:3324720
|
Barnes PJ |
New concepts in the pathogenesis of bronchial hyperresponsiveness. |
1987 |
Agents Actions Suppl. |
pmid:3314413
|
Mustard JF et al. |
Platelet activation--an overview. |
1987 |
Agents Actions Suppl. |
pmid:3314414
|
Page CP and Spina D |
The therapeutic relevance of PAF antagonists. |
1989 |
Agents Actions Suppl. |
pmid:2683635
|
Page CP and Robertson DN |
Properties of PAF relevant to asthma. |
1987 |
Agents Actions Suppl. |
pmid:3314416
|
Morley J |
PAF and airway hyperreactivity; prospects for novel prophylactic anti-asthma drugs. |
1987 |
Agents Actions Suppl. |
pmid:3314417
|
Braquet P et al. |
The role of PAF-acether in anaphylaxis demonstrated with the use of the antagonist BN 52021. |
1987 |
Agents Actions Suppl. |
pmid:3314418
|
Mest HJ et al. |
Effect of BN 52256 and other mediator antagonists on ouabain-induced ventricular fibrillation in sensitized guinea-pigs and on ischemia-induced fibrillation in rats. |
1992 |
Agents Actions Suppl. |
pmid:1632298
|
Vargaftig BB |
Phospholipids, particularly platelet-activating factor (PAF-acether), in experimental bronchoconstriction. |
1983 |
Agents Actions Suppl. |
pmid:6575594
|
Koltai M and Braquet PG |
Involvement of PAF in atherogenesis. Brief review. |
1992 |
Agents Actions Suppl. |
pmid:1632308
|
Page CP et al. |
PAF-acether: a putative mediator of asthma and inflammation. |
1983 |
Agents Actions Suppl. |
pmid:6575595
|
Morley J et al. |
Pharmacological evaluation of prophylactic anti-asthma drugs by reference to the pathological sequelae of exposure to allergen or platelet activating factor. |
1988 |
Agents Actions Suppl. |
pmid:3262989
|
Subissi A and Criscuoli M |
Effects of LG 30435 on different platelet activating factor-induced responses. |
1988 |
Agents Actions Suppl. |
pmid:3262990
|
Heuer H and Casals-Stenzel J |
Effect of the PAF-antagonist WEB 2086 on anaphylactic lung reaction: comparison of inhalative and intravenous challenge. |
1988 |
Agents Actions Suppl. |
pmid:3262991
|
Hartung HP et al. |
Stimulation of the oxidative burst in macrophages with platelet activating factor (PAF-acether). |
1982 |
Agents Actions Suppl. |
pmid:6960648
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
Stenzel H et al. |
Effect of the PAF-antagonist SRI 63-441 on the allergic reaction in awake dogs with natural asthma. |
1987 |
Agents Actions Suppl. |
pmid:2823582
|
O'Flaherty JT and Wykle RL |
Metabolic origin and fate of platelet-activating factor. |
1987 |
Agents Actions Suppl. |
pmid:2823583
|
Etienne A et al. |
Antithrombotic activity of BN 50341, a structurally new compound with anticalcic and PAF-antagonistic properties. |
1986 |
Agents Actions Suppl. |
pmid:3468781
|
|
PAF, platelets and asthma. Proceedings of a meeting. September 7-9, 1986. |
1987 |
Agents Actions Suppl. |
pmid:3478993
|
Farr RS et al. |
Platelet abnormalities in asthma--do they exist in humans? |
1987 |
Agents Actions Suppl. |
pmid:3478994
|
Menz G et al. |
Lack of PAF release in extrinsic asthma. |
1987 |
Agents Actions Suppl. |
pmid:3478995
|
Szczeklik A et al. |
Bleeding time and PAF-acether-induced platelet aggregation in atopy. |
1987 |
Agents Actions Suppl. |
pmid:3478996
|
Schmitz-Schumann M et al. |
Evidence of PAF release and platelet activation in analgesics-asthma-syndrome. |
1987 |
Agents Actions Suppl. |
pmid:3478999
|
Guinot P et al. |
Effects of BN 52063 on PAF-acether induced weal and flare in man. |
1987 |
Agents Actions Suppl. |
pmid:3479000
|
Lang M et al. |
Effects of the PAF-antagonist CV-3988 on PAF-induced changes in mucus secretion and in respiratory and circulatory variables in ferrets. |
1987 |
Agents Actions Suppl. |
pmid:3479001
|
Chini M et al. |
Effects of HAART on platelet-activating factor metabolism in naive HIV-infected patients I: study of the tenofovir-DF/emtricitabine/efavirenz HAART regimen. |
2012 |
AIDS Res. Hum. Retroviruses |
pmid:22050695
|
Lima RG et al. |
Interaction of macrophages with apoptotic cells enhances HIV Type 1 replication through PGE2, PAF, and vitronectin receptor. |
2006 |
AIDS Res. Hum. Retroviruses |
pmid:16910832
|
Tsoupras AB et al. |
Anti-platelet-activating factor effects of highly active antiretroviral therapy (HAART): a new insight in the drug therapy of HIV infection? |
2008 |
AIDS Res. Hum. Retroviruses |
pmid:18620493
|
Kelesidis T et al. |
The Role of Platelet-Activating Factor in Chronic Inflammation, Immune Activation, and Comorbidities Associated with HIV Infection. |
|
AIDS Rev |
pmid:26616844
|
Greenberg SS et al. |
Ethanol suppresses endotoxin but not platelet activating factor-induced hypotension and nitric oxide. |
1996 |
Alcohol. Clin. Exp. Res. |
pmid:8904980
|
Saleh AA et al. |
Effect of alcohol on platelet-activating factor acetylhydrolase activity in pregnant and nonpregnant mice. |
1994 |
Alcohol. Clin. Exp. Res. |
pmid:7978079
|
Baker RC et al. |
Effects of ethanol on human platelets stimulated with platelet-activating factor, a biologically active ether phospholipid. |
1989 |
Alcohol. Clin. Exp. Res. |
pmid:2557776
|
Lands WE |
Cellular signals in alcohol-induced liver injury: a review. |
1995 |
Alcohol. Clin. Exp. Res. |
pmid:7485841
|
Ligumsky M et al. |
The role of platelet activating factor [correction of actor] in acute gastric injury and its protection by sucralfate. |
1990 |
Aliment. Pharmacol. Ther. |
pmid:2129638
|
Rihoux JP |
[Allergic reaction and vascular permeability]. |
1990 |
Allerg Immunol (Paris) |
pmid:2288644
|
Beauvais F and Benveniste J |
[IgE and anaphylaxis mediators]. |
1987 |
Allerg Immunol (Paris) |
pmid:2968802
|
Mencia-Huerta JM et al. |
[Effect of long-term administration of platelet activating factor on pulmonary response and morphology in the guinea pig]. |
1988 |
Allerg Immunol (Paris) |
pmid:3245884
|
Negro Alvarez JM et al. |
Platelet-activating factor antagonists. |
1997 Sep-Oct |
Allergol Immunopathol (Madr) |
pmid:9395010
|
MonteseirÃn J et al. |
Formation of lipids, peptides and cytokines. |
1996 Sep-Oct |
Allergol Immunopathol (Madr) |
pmid:8985477
|
Miadonna A et al. |
Induction and control of allergic inflammation in human respiratory airways. |
1993 May-Jun |
Allergol Immunopathol (Madr) |
pmid:7689291
|
Mukai K et al. |
New insights into the roles for basophils in acute and chronic allergy. |
2009 |
Allergol Int |
pmid:19153532
|
Oxholm P and Winther K |
Thrombocyte involvement in immune inflammatory reactions. |
1986 |
Allergy |
pmid:3515999
|
Kurosawa M et al. |
Increased levels of blood platelet-activating factor in bronchial asthmatic patients with active symptoms. |
1994 |
Allergy |
pmid:8198242
|
Mishra RK et al. |
Differential dependence of eosinophil chemotactic responses on phosphoinositide 3-kinase (PI3K). |
2005 |
Allergy |
pmid:16076309
|
Mullol J et al. |
Update on rupatadine in the management of allergic disorders. |
2015 |
Allergy |
pmid:25491409
|
Schauer U et al. |
Enhanced production of platelet activating factor by peripheral granulocytes from children with asthma. |
1992 |
Allergy |
pmid:1514664
|
Egesten A and Malm J |
Eosinophil leukocyte degranulation in response to serum-opsonized beads: C5a and platelet-activating factor enhance ECP release, with roles for protein kinases A and C. |
1998 |
Allergy |
pmid:9860239
|
Woo HY et al. |
Mechanism for acute oral desensitization to antibiotics. |
2006 |
Allergy |
pmid:16867049
|
Howarth PH |
Mediators of nasal blockage in allergic rhinitis. |
1997 |
Allergy |
pmid:9353555
|
Zuberbier T et al. |
Histamine releasability of basophils and skin mast cells in chronic urticaria. |
1996 |
Allergy |
pmid:8721524
|
Zeck-Kapp G et al. |
Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. |
1995 |
Allergy |
pmid:7741187
|
Krause K et al. |
Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation. |
2013 |
Allergy |
pmid:23320562
|
Bachert C |
Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis. |
2001 |
Allergy |
pmid:11243500
|
Oxholm P et al. |
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study. |
1984 |
Allergy |
pmid:6528957
|
Dunoyer-Geindre S et al. |
PAF acether release on antigenic challenge. A method for the investigation of drug allergic reactions. |
1992 |
Allergy |
pmid:1590567
|
Mullol J et al. |
Rupatadine in allergic rhinitis and chronic urticaria. |
2008 |
Allergy |
pmid:18339040
|
Juhlin L |
A comparison of the pharmacodynamics of H1-receptor antagonists as assessed by the induced wheal-and-flare model. |
1995 |
Allergy |
pmid:7645678
|
Meltzer EO |
The use of anti-H1 drugs in mild asthma. |
1995 |
Allergy |
pmid:7645681
|
Pipkorn U et al. |
Effect of platelet activating factor on the human nasal mucosa. |
1984 |
Allergy |
pmid:6703263
|
Takafuji S et al. |
Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a. |
1996 |
Allergy |
pmid:8874660
|
Di Leo E et al. |
Treatment of acquired cold urticaria with rupatadine. |
2009 |
Allergy |
pmid:19392988
|
Soyombo O et al. |
Effects of lipoxin A4 on chemotaxis and degranulation of human eosinophils stimulated by platelet-activating factor and N-formyl-L-methionyl-L-leucyl-L-phenylalanine. |
1994 |
Allergy |
pmid:8037356
|
Takafuji S et al. |
Release of granule proteins from human eosinophils stimulated with mast-cell mediators. |
1998 |
Allergy |
pmid:9821474
|
Maniscalco M et al. |
The effect of platelet-activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide. |
2000 |
Allergy |
pmid:10955702
|
Leggieri E et al. |
Study of the effects of paf-acether on human nasal airways. |
1991 |
Allergy |
pmid:1720286
|
Rosenwasser L |
New insights into the pathophysiology of allergic rhinitis. |
2007 Jan-Feb |
Allergy Asthma Proc |
pmid:17390750
|
Klettke U et al. |
Platelet-activating factor inhibits ciliary beat frequency of human bronchial epithelial cells. |
1999 Mar-Apr |
Allergy Asthma Proc |
pmid:10209689
|
Babayigit A et al. |
Effects of Ginkgo biloba on airway histology in a mouse model of chronic asthma. |
2009 Mar-Apr |
Allergy Asthma Proc |
pmid:19118503
|
Gleich GJ and Abu-Ghazaleh R |
Update on eosinophils. |
1989 Jan-Feb |
Allergy Proc |
pmid:2925087
|
Chung KF et al. |
Platelet activating factor: effects on bronchomotor tone and bronchial responsiveness in human beings. |
1989 Sep-Oct |
Allergy Proc |
pmid:2684754
|
Nabe M et al. |
The effect of ketotifen on eosinophils as measured at LTC4 release and by chemotaxis. |
1991 Jul-Aug |
Allergy Proc |
pmid:1936977
|
|
Coleus forskohlii. Monograph. |
2006 |
Altern Med Rev |
pmid:16597194
|
McKenna DJ et al. |
Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. |
2001 Sep-Oct |
Altern Ther Health Med |
pmid:11565403
|
Sills RH |
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations. |
1984 |
Am J Pediatr Hematol Oncol |
pmid:6442830
|
Müllers SM et al. |
Altered Platelet Function in Intrauterine Growth Restriction: A Cause or a Consequence of Uteroplacental Disease? |
2016 |
Am J Perinatol |
pmid:26906182
|
Adamson LM et al. |
Mechanistic studies of early pregnancy associated thrombocytopenia (EPAT) in the mouse. |
1987 |
Am J Reprod Immunol Microbiol |
pmid:3605486
|
Cingi C et al. |
The histopathological effect of thymoquinone on experimentally induced rhinosinusitis in rats. |
2011 Nov-Dec |
Am J Rhinol Allergy |
pmid:22185737
|
Muñoz-Cano R et al. |
Platelet-activating factor nasal challenge induces nasal congestion and reduces nasal volume in both healthy volunteers and allergic rhinitis patients. |
2013 Mar-Apr |
Am J Rhinol Allergy |
pmid:23562190
|
Liu Q et al. |
The effect of lexipafant on bacterial translocation in acute necrotizing pancreatitis in rats. |
1999 |
Am Surg |
pmid:10399968
|
Hebra A et al. |
Systemic and mesenteric vascular effects of platelet-activating factor and cocaine. In vivo effects on a neonatal swine model. |
1993 |
Am Surg |
pmid:8480932
|